10019-115 : Brevibloc 10 mg/ml Intravenous Injection
NDC: | 10019-115 |
Labeler: | Baxter Healthcare Corporation |
Product Type: | Human Prescription Drug |
Drug Name: | Brevibloc |
Dosage Form: | Intravenous Injection |
Application #: | NDA019386 |
Rev. Date: |
NDC Package Codes:
- 10019-115-01: 25 VIAL IN 1 CARTON (10019‑115‑01) > 10 ML IN 1 VIAL (10019‑115‑39)
Active Ingredients:
- Esmolol Hydrochloride
Dosage Strength:
- 10 mg/mL
Pharmaceutical Classes:
- Adrenergic beta-Antagonists [MoA]
- beta-Adrenergic Blocker [EPC]
Related Products:
Based on records with the same trade name.- 10019-055 Brevibloc 10 mg/ml Intravenous Injection by Baxter Healthcare Corporation
- 10019-075 Brevibloc 20 mg/ml Intravenous Injection by Baxter Healthcare Corporation
- 10019-666 Brevibloc 20 mg/ml Intravenous Injection by Baxter Healthcare Corporation
- 10019-668 Brevibloc 20 mg/ml Intravenous Injection by Baxter Healthcare Corporation
- 10019-670 Brevibloc 10 mg/ml Intravenous Injection by Baxter Healthcare Corporation
- 10019-672 Brevibloc 10 mg/ml Intravenous Injection by Baxter Healthcare Corporation
- 0404-9825 Brevibloc 10 mg/ml Intravenous Injection by Henry Schein, Inc
- 52584-115 Brevibloc 10 mg/ml Intravenous Injection, Solution by General Injectables & Vaccines
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 10019-106Next: 10019-120 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.